Lasa Supergenerics share news, announcements and annual reports
NSE: LASABSE: 540702Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 26 Oct 2026. Previous close ₹4.91.
26 Oct: open ₹4.86, high ₹4.86, low ₹4.67
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹23 Cr3,595th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.47
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −24.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 42,091
Lasa Supergenerics share news and announcements
825 announcements, routine notices left out, newest first. Page 3 of 17.
Jul 2025
18 Jul
18 Jul · Announcement Under Regulation 30 SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015- Update On Factory Operations Post Fire Incident
Jun 2025
24 Jun
24 Jun · Updates On Restart Of Manufacturing Operations
3 Jun
3 Jun · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure With The Reference To Withdraw Of Warrants Of The Promoter
May 2025
28 May · Related Party Transaction For The Quarter And The Year Ended March 31, 2025
28 May · Results
28 May · Results
28 May · Board meeting
28 May · Board meeting
26 May
26 May · Postponement Of Board Meeting Scheduled On 28.05.2025
21 May · Board meeting
19 May · Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
16 May · Board meeting
6 May
Apr 2025
18 Apr
18 Apr · Declaration With Respect To Non- Applicabitlity Of Large Entity
Mar 2025
Feb 2025
13 Feb · Board meeting
13 Feb · Board meeting
13 Feb · Results
11 Feb · General Updates
5 Feb · Board meeting
Jan 2025
28 Jan
28 Jan · Announcement under Regulation 30 (LODR)-Raising of Funds
28 Jan · Board meeting
28 Jan · Board meeting
22 Jan · Board meeting